Results from these experiments determined that oxaliplatin‐loaded EVs conjugated with GE11 peptide showed significantly higher incorporation into EGFR‐expressing cancer cells compared to those without GE11 peptide conjugation, leading to increased apoptosis of cancer cells. This evidence concerns the gene EGFR and cancer.